160 related articles for article (PubMed ID: 21161647)
1. Experimentally induced hyperoxaluria in MCP-1 null mice.
Khan SR; Glenton PA
Urol Res; 2011 Aug; 39(4):253-8. PubMed ID: 21161647
[TBL] [Abstract][Full Text] [Related]
2. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.
Zuo J; Khan A; Glenton PA; Khan SR
Nephrol Dial Transplant; 2011 Jun; 26(6):1785-96. PubMed ID: 21378157
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition.
Tsuji H; Shimizu N; Nozawa M; Umekawa T; Yoshimura K; De Velasco MA; Uemura H; Khan SR
Urolithiasis; 2014 Jun; 42(3):195-202. PubMed ID: 24619192
[TBL] [Abstract][Full Text] [Related]
4. Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts.
Umekawa T; Iguchi M; Uemura H; Khan SR
BJU Int; 2006 Sep; 98(3):656-60. PubMed ID: 16925768
[TBL] [Abstract][Full Text] [Related]
5. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys.
Umekawa T; Hatanaka Y; Kurita T; Khan SR
J Am Soc Nephrol; 2004 Mar; 15(3):635-44. PubMed ID: 14978165
[TBL] [Abstract][Full Text] [Related]
7. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
8. Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria.
Wang X; Bhutani G; Vaughan LE; Enders FT; Haskic Z; Milliner D; Lieske JC;
BMC Nephrol; 2020 Apr; 21(1):133. PubMed ID: 32293313
[TBL] [Abstract][Full Text] [Related]
9. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition.
Joshi S; Wang W; Khan SR
PLoS One; 2017; 12(11):e0185009. PubMed ID: 29091707
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals.
Umekawa T; Chegini N; Khan SR
Nephrol Dial Transplant; 2003 Apr; 18(4):664-9. PubMed ID: 12637633
[TBL] [Abstract][Full Text] [Related]
12. Experimental induction of calcium oxalate nephrolithiasis in mice.
Khan SR; Glenton PA
J Urol; 2010 Sep; 184(3):1189-96. PubMed ID: 20663521
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
Wesson JA; Johnson RJ; Mazzali M; Beshensky AM; Stietz S; Giachelli C; Liaw L; Alpers CE; Couser WG; Kleinman JG; Hughes J
J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
[TBL] [Abstract][Full Text] [Related]
14. Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice.
Li Y; Zhang J; Liu H; Yuan J; Yin Y; Wang T; Cheng B; Sun S; Guo Z
Phytomedicine; 2019 Aug; 61():152861. PubMed ID: 31029908
[TBL] [Abstract][Full Text] [Related]
15. Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter.
Khan SR; Glenton PA
Am J Physiol Renal Physiol; 2008 May; 294(5):F1109-15. PubMed ID: 18337544
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells.
Habibzadegah-Tari P; Byer KG; Khan SR
Urol Res; 2006 Feb; 34(1):26-36. PubMed ID: 16397773
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
Liu CJ; Tsai YS; Huang HS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328466
[TBL] [Abstract][Full Text] [Related]
18. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies.
Khan SR
Clin Exp Nephrol; 2004 Jun; 8(2):75-88. PubMed ID: 15235923
[TBL] [Abstract][Full Text] [Related]
19. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.
Geraghty R; Wood K; Sayer JA
Urolithiasis; 2020 Oct; 48(5):377-384. PubMed ID: 32719990
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXA11-AS regulates calcium oxalate crystal-induced renal inflammation via miR-124-3p/MCP-1.
Li Y; Yan G; Zhang J; Chen W; Ding T; Yin Y; Li M; Zhu Y; Sun S; Yuan JH; Guo Z
J Cell Mol Med; 2020 Jan; 24(1):238-249. PubMed ID: 31680444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
